Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | TPX-0022 |
Trade Name | |
Synonyms | TPX0022|TPX 0022|elzovantinib |
Drug Descriptions |
TPX-0022 inhibits Met, Csf1r, and Src, which may lead to growth inhibition in tumor cells (Proceedings of the American Association for Cancer Research, Vol 60, Mar 2019, Abstract #1321). |
DrugClasses | CSF1R Inhibitor 28 MET Inhibitor 59 SRC Inhibitor 31 |
CAS Registry Number | NA |
NCIT ID | C162676 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TPX-0022 | TPX-0022 | 0 | 1 |